EUVIMEDEUVIMED entdecken
Open Access

Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine

Nadja A Vielot iD, Michele Jonsson Funk iD, Til Stürmer iD, Jonathan Fix, Sylvia Becker-Dreps iD, David J Weber, Jennifer L Lund iD

Annals of Internal Medicine · 2025

DOI: 10.7326/annals-24-02409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Internal Medicine, 2025. Verfasst von Nadja A Vielot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (N.A.V.). Hauptthemen laut MEDLINE: Herpes Zoster Vaccine, Herpes Zoster, Immunocompetence, Vaccine Efficacy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes Zoster VaccineHerpes ZosterImmunocompetenceVaccine EfficacyHumansUnited StatesAgedMaleMedicareVaccines, SyntheticFemaleAged, 80 and overVaccines, Attenuated

Substanzen

Herpes Zoster VaccineVaccines, SyntheticVaccines, Attenuated

Autor:innen und Institutionen

  • Department of Family Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (N.A.V.).
  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (M.J.F., T.S., J.L.L.).
  • Global Vaccine Safety, Novavax, Gaithersburg, Maryland (J.F.).
  • Department of Family Medicine, School of Medicine, and Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (S.B.).
  • Department of Epidemiology, Gillings School of Global Public Health, and Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (D.J.W.).

ORCID-Profile: Nadja A Vielot, Michele Jonsson Funk, Til Stürmer, Sylvia Becker-Dreps, Jennifer L Lund

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Vielot, N. A., Jonsson Funk, M., Stürmer, T., Fix, J., Becker-Dreps, S., Weber, D. J., & Lund, J. L. (2025). Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine. Annals of Internal Medicine. https://doi.org/10.7326/annals-24-02409

Vancouver

Vielot NA, Jonsson Funk M, Stürmer T, Fix J, Becker-Dreps S, Weber DJ, et al. Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine. Annals of Internal Medicine. 2025. doi:10.7326/annals-24-02409

BibTeX
@article{Vielot2025,
  author = {Vielot, Nadja A and Jonsson Funk, Michele and Stürmer, Til and Fix, Jonathan and Becker-Dreps, Sylvia and Weber, David J and Lund, Jennifer L},
  title = {Effectiveness of Recombinant Herpes Zoster Vaccine in the U.S. Medicare Population, 2018 to 2019, by Immunocompetence and Prior Receipt of Live Zoster Vaccine},
  journal = {Annals of Internal Medicine},
  year = {2025},
  doi = {10.7326/annals-24-02409}
}
Kostenlos starten →